Cargando…
Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment
SIMPLE SUMMARY: Pancreatic cancer has a five-year survival rate of less than 8% and is the fourth leading cause of cancer death in the United States. Existing therapeutics have failed to improve pancreatic ductal adenocarcinoma (PDAC) patient outcomes. There has been success with other tumor types i...
Autores principales: | Nakkina, Sai Preethi, Gitto, Sarah B., Pandey, Veethika, Parikh, Jignesh G., Geerts, Dirk, Maurer, Hans Carlo, Olive, Kenneth P., Phanstiel, Otto, Altomare, Deborah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699198/ https://www.ncbi.nlm.nih.gov/pubmed/34945011 http://dx.doi.org/10.3390/cancers13246391 |
Ejemplares similares
-
DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment
por: Nakkina, Sai Preethi, et al.
Publicado: (2021) -
A novel polyamine blockade therapy activates an anti-tumor immune response
por: Alexander, Eric T., et al.
Publicado: (2017) -
Polyamine-Based Nanostructures Share Polyamine Transport Mechanisms with Native Polyamines and Their Analogues: Significance for Polyamine-Targeted Therapy
por: Holbert, Cassandra E., et al.
Publicado: (2022) -
A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors
por: Peters, Molly C., et al.
Publicado: (2018) -
Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers
por: Massaro, Chelsea, et al.
Publicado: (2017)